Sertraline Hydrochloride

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 69097-451
  • Package NDC 69097-451-02
  • Application number ANDA218853
  • SPL ID d93baba8-ca39-4dd5-bcda-5def49b56e2a
  • SPL set ID 3a3efb5f-b24a-438d-9253-371ff3b5417d
  • UNII UTI8907Y6X
  • RxCUI 251201
  • RxCUI 410584

What the source publishes

Labeler
Cipla USA Inc.
Active ingredients
Sertraline Hydrochloride
Form
CAPSULE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:69097-451_d93baba8-ca39-4dd5-bcda-5def49b56e2a
{
  "name": "Sertraline Hydrochloride",
  "splId": "d93baba8-ca39-4dd5-bcda-5def49b56e2a",
  "labels": [
    {
      "setId": "3a3efb5f-b24a-438d-9253-371ff3b5417d",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3a3efb5f-b24a-438d-9253-371ff3b5417d",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3a3efb5f-b24a-438d-9253-371ff3b5417d"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Cipla USA Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 CAPSULE in 1 BOTTLE (69097-451-02)",
      "package_ndc": "69097-451-02",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250717"
    }
  ],
  "productId": "69097-451_d93baba8-ca39-4dd5-bcda-5def49b56e2a",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE",
  "productNdc": "69097-451",
  "deaSchedule": null,
  "genericName": "Sertraline Hydrochloride",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "SERTRALINE HYDROCHLORIDE",
      "strength": "200 mg/1"
    }
  ],
  "applicationNumber": "ANDA218853",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20250717",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0369097438029"
    ],
    "unii": [
      "UTI8907Y6X"
    ],
    "rxcui": [
      "251201",
      "410584"
    ],
    "spl_set_id": [
      "3a3efb5f-b24a-438d-9253-371ff3b5417d"
    ],
    "manufacturer_name": [
      "Cipla USA Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:69097-451_d93baba8-ca39-4dd5-bcda-5def49b56e2a"